First liposomal amphotericin B powder for injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
News
Second rectal artesunate capsule prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Ipca's paediatric artemether/lumefantrine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Labesfal's Mg injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Hisun's kanamycin injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
MSN's moxifloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
ViiV Healthcare's abacavir/lamivudine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Hetero's paediatric lopinavir/ritonavir tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Questions and answers on DTG use in women of childbearing age
M
On 18 May 2018, WHO has issued a web statement signalling a potential risk of neural tube defects in infants born to women who were taking dolutegravir (DTG) at the time of conception.
ICHQ3D introduced for APIMF and API prequalification procedures
M
The ICHQ3D guideline presents a process to assess and control elemental impurities in drug products using the principles of risk assessment.
Report on the international API inspection programme 2011 - 2016
M
In April 2018, EMA published a report with an overview of the activities of the programme between 2011 and 2016.
First amikacin injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Newly prequalified Quality Control Laboratory (QCL)
M
New addition to the List of Prequalified Quality Control
HLL’s levonorgestrel prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Newly prequalified Quality Control Laboratory (QCL)
M
New addition to the List of Prequalified Quality Control Laboratories (QCLs):
First flucytosine prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First dispersible paediatric ethambutol prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Riemser Pharma's protionamide prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Riemser Pharma's terizidone prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First rectal artesunate prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First dispersible paediatric levofloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Roche's ceftriaxone powder for injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
UPDATE: WHO Position paper on Qinhuangdao Zizhu Pharmaceutical Co Ltd, Active Pharmaceutical Ingredient (API) manufacturing site following the issue of the USFDA import alert
M
On 07 April 2017, WHO issued a position paper on the import alert placed on, Qinhuangdao Zizhu Pharmaceutical (QZP) by the United States Food and Drug Administration (USFDA) on 8 March 2017. This
Hetero’s sofosbuvir tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list: